# Frederic Dijols

> Frederic Dijols is the co-founder and CEO of Mixlab, a veterinary-exclusive pet pharmacy that compounds custom medications and delivers them fast and free to pet parents and the vets who prescribe them. A French-trained engineer with degrees from Ecole Polytechnique, Stanford, and Harvard Business School, he traded a healthcare-banking seat at J.P. Morgan for a pharmacy floor after a miserable experience getting meds for his aging pug, Bob. Since 2017 he has raised roughly $46.5M and built Mixlab into a multi-state operation pairing pharmacist-grade compounding with consumer-grade delight.

- **Role:** Co-Founder & CEO at Mixlab
- **Organizations:** Mixlab, J.P. Morgan, Johnson & Johnson, Conor Medsystems
- **Nationality:** French
- **Education:** MBA, Harvard Business School, MS, Mechanical & Biomedical Engineering, Stanford University, Diplome d'Ingenieur (Applied Math, Microeconomics, Fluid Mechanics), Ecole Polytechnique, Preparatory studies, College Stanislas, Paris
- **Known for:** Co-founded and scaled Mixlab into a multi-state veterinary-exclusive compounding pharmacy, Raised approximately $46.5M in total funding across multiple rounds, Built a PCAB-accredited compounding operation serving vets and pet parents nationwide

## Career timeline

- **2006** — Joined Johnson & Johnson / Conor Medsystems as a Senior R&D Engineer
- **2011** — Began MBA at Harvard Business School
- **2013** — Joined J.P. Morgan as an Associate on the healthcare banking team
- **2017** — Co-founded Mixlab with Stella Kim and Vinnie Dam; became CEO
- **2019** — Raised $8.5M for the modern pet pharmacy
- **2021** — Raised $20M Series A led by Sonoma Brands
- **2022** — Appointed Mixlab's first Chief Operating Officer
- **2023** — Raised a $10M Series A extension led by Vanterra Ventures (total ~$40.5M)
- **2025** — Expanded into the Midwest by acquiring The Pet Apothecary and SBH's veterinary business

## Achievements

- Co-founded and scaled Mixlab into a multi-state veterinary-exclusive compounding pharmacy
- Raised approximately $46.5M in total funding across multiple rounds
- Built a PCAB-accredited compounding operation serving vets and pet parents nationwide
- Achieved 94% veterinarian CSAT and a 92 pet-parent NPS
- Led 2025 acquisition of The Pet Apothecary to expand Midwest operations
- Kept service running without a single closed day through the COVID-19 pandemic

## Latest updates

- **2025-01** — Mixlab acquired The Pet Apothecary and SBH's veterinary business to expand Midwest operations.
- **2023-08** — Closed a $10M Series A extension led by Vanterra Ventures.

## Links

- Website: https://mixlab.com
- LinkedIn: https://www.linkedin.com/in/fdijols/
- Twitter/X: https://twitter.com/mixlabrx
- Facebook: https://www.facebook.com/mixlabrx/

---

Profile page: https://yespress.io/frederic-dijols
Published by YesPress — https://yespress.io
Last updated: 2026-06-12